001     1027709
005     20250203103452.0
024 7 _ |a 10.1055/s-0043-1766157
|2 doi
037 _ _ |a FZJ-2024-04019
100 1 _ |a Michno, M.
|0 P:(DE-Juel1)191151
|b 0
|e Corresponding author
|u fzj
111 2 _ |a 61. Jahrestagung der Deutschen Gesellschaft für Nuklearmedizin
|c Leipzig
|d 2023-04-19 - 2023-04-22
|w Germany
245 _ _ |a Effect of acute hypoxia exposure on the availability of A1 adenosine receptors in the human brain measured with [F-18]CPFPX PET
260 _ _ |c 2023
336 7 _ |a Conference Paper
|0 33
|2 EndNote
336 7 _ |a Other
|2 DataCite
336 7 _ |a INPROCEEDINGS
|2 BibTeX
336 7 _ |a conferenceObject
|2 DRIVER
336 7 _ |a LECTURE_SPEECH
|2 ORCID
336 7 _ |a Conference Presentation
|b conf
|m conf
|0 PUB:(DE-HGF)6
|s 1719375542_17792
|2 PUB:(DE-HGF)
|x After Call
520 _ _ |a Ziel/Aim Normobaric hypoxia induces numerous adaptive changes, e. g., incerebral blood flow, metabolism and electrical activity. Adenosine, as an inhibitoryneuromodulator, is produced in and/or released to the interstitial spaceduring hypoxia and assumed to mediate several of these effects. A1 adenosinereceptor (A1AR) antagonism or knock-out attenuates this neuronal inhibitionin mice. Here we tested the hypothesis that exposure to an interval of hypoxiacompared to an interval of normoxia (control) reduces the availability of A1ARin the human brain, due to hypoxia-triggered rise of endogenous adenosine.As exploratory objectives, we tested the hypotheses that psychomotor vigilanceis affected during hypoxia and that cerebral blood flow is altered.Methodik/Methods Ten healthy volunteers (32 ± 13 years, 3f) completed an110-min bolus plus constant infusion [F-18]CPFPX PET-MRI hybrid experiment:Subjects spent the first 60 minutes of the scan in normoxia followed by 30minutes of individually adapted normobaric hypoxia to achieve a peripheraloxygen saturation of 70 - 75 %, followed by 20 minutes of normoxia. Bloodsamples were used to calculate metabolite-corrected steady-state distributionvolumes (VT) of A1AR (i. e., 40 – 100 min after start of [F-18]CPFPX administration).Brain perfusion was measured via arterial spin labelling. A 3-minutepsychomotor vigilance test (PVT) was conducted every 10 minutes. Heart rateand peripheral blood oxygen saturation were measured continuously.Ergebnisse/Results Hypoxia reduced A1AR availability in the cerebral cortexby 11 % (p = 0.033). Compared to normoxia, brain perfusion increased duringhypoxia by 25 % in cortical gray matter (p < 0.001). Heart rate increased by 22 %(p < 0.001). PVT mean reaction time was longer by 7 ms (p = 0.027).Schlussfolgerungen/Conclusions Short term reduction of the oxygen saturationto 70 % (corresponding to an oxygen saturation at an altitude of approximately6000 m) increases cerebral blood flow and impairs cognitive performancewhile A1AR availability is reduced. This indicates that acute hypoxiaexposure increases cerebral adenosine concentration and receptor occupancy.
536 _ _ |a 5253 - Neuroimaging (POF4-525)
|0 G:(DE-HGF)POF4-5253
|c POF4-525
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef Conference
700 1 _ |a Weis, H.
|0 P:(DE-HGF)0
|b 1
700 1 _ |a Schmitz, J.
|0 P:(DE-HGF)0
|b 2
700 1 _ |a Foerges, Anna Linea
|0 P:(DE-Juel1)179271
|b 3
|u fzj
700 1 _ |a Beer, Simone
|0 P:(DE-Juel1)133864
|b 4
|u fzj
700 1 _ |a Neumaier, B.
|0 P:(DE-Juel1)166419
|b 5
|u fzj
700 1 _ |a Drzezga, A.
|0 P:(DE-Juel1)177611
|b 6
|u fzj
700 1 _ |a Aeschbach, D.
|0 P:(DE-HGF)0
|b 7
700 1 _ |a Bauer, Andreas
|0 P:(DE-Juel1)131672
|b 8
|u fzj
700 1 _ |a Tank, J.
|0 P:(DE-HGF)0
|b 9
700 1 _ |a Elmenhorst, E.
|0 P:(DE-HGF)0
|b 10
700 1 _ |a Elmenhorst, D.
|0 P:(DE-Juel1)131679
|b 11
|u fzj
773 _ _ |a 10.1055/s-0043-1766157
909 C O |o oai:juser.fz-juelich.de:1027709
|p VDB
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 0
|6 P:(DE-Juel1)191151
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 3
|6 P:(DE-Juel1)179271
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 4
|6 P:(DE-Juel1)133864
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 5
|6 P:(DE-Juel1)166419
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 6
|6 P:(DE-Juel1)177611
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 8
|6 P:(DE-Juel1)131672
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 11
|6 P:(DE-Juel1)131679
913 1 _ |a DE-HGF
|b Key Technologies
|l Natural, Artificial and Cognitive Information Processing
|1 G:(DE-HGF)POF4-520
|0 G:(DE-HGF)POF4-525
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-500
|4 G:(DE-HGF)POF
|v Decoding Brain Organization and Dysfunction
|9 G:(DE-HGF)POF4-5253
|x 0
914 1 _ |y 2024
920 _ _ |l yes
920 1 _ |0 I:(DE-Juel1)INM-5-20090406
|k INM-5
|l Nuklearchemie
|x 0
980 _ _ |a conf
980 _ _ |a VDB
980 _ _ |a I:(DE-Juel1)INM-5-20090406
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21